Connection

Erin McClure to Humans

Back to Details
This is a "connection" page, showing publications Erin McClure has written about Humans.
Erin McClure
Connection Strength
0.956
Humans
  1. Determining the impact of cannabis use and severity on tobacco cessation outcomes: study protocol for a prospective tobacco treatment trial. BMC Psychol. 2023 Jan 25; 11(1):25.
    View in: PubMed
    Score: 0.033
  2. Cannabis and nicotine co-use among primary care patients in a state with legal cannabis access. Addict Behav. 2023 05; 140:107621.
    View in: PubMed
    Score: 0.033
  3. A pilot feasibility study of a behavioral intervention for nicotine vaping cessation among young adults delivered via telehealth. Drug Alcohol Depend. 2022 03 01; 232:109311.
    View in: PubMed
    Score: 0.031
  4. Evaluating N-acetylcysteine for early and end-of-treatment abstinence in adult cigarette smokers. Drug Alcohol Depend. 2021 08 01; 225:108815.
    View in: PubMed
    Score: 0.030
  5. Accurate and sufficient measurement of cannabis and tobacco co-use: agreement, consensus and the path forward. Addiction. 2021 07; 116(7):1636-1637.
    View in: PubMed
    Score: 0.029
  6. Mobile, Remote, and Individual Focused: Comparing Breath Carbon Monoxide Readings and Abstinence Between Smartphone-Enabled and Stand-Alone Monitors. Nicotine Tob Res. 2021 03 19; 23(4):741-747.
    View in: PubMed
    Score: 0.029
  7. Unknown population-level harms of cannabis and tobacco co-use: if you don't measure it, you can't manage it. Addiction. 2021 07; 116(7):1622-1630.
    View in: PubMed
    Score: 0.028
  8. Cannabis and Alcohol Co-Use in a Smoking Cessation Pharmacotherapy Trial for Adolescents and Emerging Adults. Nicotine Tob Res. 2020 07 16; 22(8):1374-1382.
    View in: PubMed
    Score: 0.028
  9. Examining sex, adverse childhood experiences, and oxytocin on neuroendocrine reactivity in smokers. Psychoneuroendocrinology. 2020 10; 120:104752.
    View in: PubMed
    Score: 0.028
  10. Commentary on Guillaumier et al. (2020): Is harm reduction a suitable outcome for historically hard-to-treat smokers? Addiction. 2020 07; 115(7):1356-1357.
    View in: PubMed
    Score: 0.027
  11. The influence of gender and oxytocin on stress reactivity, cigarette craving, and smoking in a randomized, placebo-controlled laboratory relapse paradigm. Psychopharmacology (Berl). 2020 Feb; 237(2):543-555.
    View in: PubMed
    Score: 0.027
  12. Tobacco and cannabis co-use: Drug substitution, quit interest, and cessation preferences. Exp Clin Psychopharmacol. 2019 Jun; 27(3):265-275.
    View in: PubMed
    Score: 0.025
  13. Tobacco and cannabis co-use and interrelatedness among adults. Addict Behav. 2019 03; 90:354-361.
    View in: PubMed
    Score: 0.025
  14. Tobacco use during cannabis cessation: Use patterns and impact on abstinence in a National Drug Abuse Treatment Clinical Trials Network study. Drug Alcohol Depend. 2018 11 01; 192:59-66.
    View in: PubMed
    Score: 0.024
  15. Acceptability and compliance with a remote monitoring system to track smoking and abstinence among young smokers. Am J Drug Alcohol Abuse. 2018; 44(5):561-570.
    View in: PubMed
    Score: 0.024
  16. Assessing the Digital Divide Among Low-Income Perinatal Women: Opportunities for Provision of Health Information and Counseling. Telemed J E Health. 2019 01; 25(1):48-54.
    View in: PubMed
    Score: 0.024
  17. Introduction to the special issue: Utilizing ambulatory assessment to better understand the etiology, maintenance, treatment, and remission of addictive disorders. Addict Behav. 2018 08; 83:1-4.
    View in: PubMed
    Score: 0.024
  18. Using REDCap for ambulatory assessment: Implementation in a clinical trial for smoking cessation to augment in-person data collection. Am J Drug Alcohol Abuse. 2019; 45(1):26-41.
    View in: PubMed
    Score: 0.024
  19. Tobacco Use Prevalence and Outcomes Among Perinatal Patients Assessed Through an "Opt-out" Cessation and Follow-Up Clinical Program. Matern Child Health J. 2017 Sep; 21(9):1790-1797.
    View in: PubMed
    Score: 0.023
  20. Comparing adult cannabis treatment-seekers enrolled in a clinical trial with national samples of cannabis users in the United States. Drug Alcohol Depend. 2017 07 01; 176:14-20.
    View in: PubMed
    Score: 0.022
  21. Objective and subjective memory ratings in cannabis-dependent adolescents. Am J Addict. 2015 Jan; 24(1):47-52.
    View in: PubMed
    Score: 0.019
  22. Cigarette Smoking During Substance Use Disorder Treatment: Secondary Outcomes from a National Drug Abuse Treatment Clinical Trials Network study. J Subst Abuse Treat. 2015 Jun; 53:39-46.
    View in: PubMed
    Score: 0.019
  23. Achieving cannabis cessation -- evaluating N-acetylcysteine treatment (ACCENT): design and implementation of a multi-site, randomized controlled study in the National Institute on Drug Abuse Clinical Trials Network. Contemp Clin Trials. 2014 Nov; 39(2):211-23.
    View in: PubMed
    Score: 0.018
  24. An open-label pilot trial of N-acetylcysteine and varenicline in adult cigarette smokers. Am J Drug Alcohol Abuse. 2015 Jan; 41(1):52-6.
    View in: PubMed
    Score: 0.018
  25. Cigarette smoking during an N-acetylcysteine-assisted cannabis cessation trial in adolescents. Am J Drug Alcohol Abuse. 2014 Jul; 40(4):285-91.
    View in: PubMed
    Score: 0.018
  26. Potential role of N-acetylcysteine in the management of substance use disorders. CNS Drugs. 2014 Feb; 28(2):95-106.
    View in: PubMed
    Score: 0.018
  27. Characterizing smoking, cessation services, and quit interest across outpatient substance abuse treatment modalities. J Subst Abuse Treat. 2014 Feb; 46(2):194-201.
    View in: PubMed
    Score: 0.017
  28. Smoking topography and abstinence in adult female smokers. Addict Behav. 2013 Dec; 38(12):2833-6.
    View in: PubMed
    Score: 0.017
  29. Utilization of communication technology by patients enrolled in substance abuse treatment. Drug Alcohol Depend. 2013 Apr 01; 129(1-2):145-50.
    View in: PubMed
    Score: 0.016
  30. Effects of varenicline on abstinence and smoking reward following a programmed lapse. Nicotine Tob Res. 2013 Jan; 15(1):139-48.
    View in: PubMed
    Score: 0.016
  31. Introduction to special issue of addictive behaviors: Tobacco regulatory science. Addict Behav. 2023 Jul; 142:107671.
    View in: PubMed
    Score: 0.008
  32. Characterization of Salivary Progesterone in Female Smokers. Nicotine Tob Res. 2022 10 26; 24(11):1829-1833.
    View in: PubMed
    Score: 0.008
  33. Daily Cannabis Use Is a Barrier to Tobacco Cessation Among Tobacco Quitline Callers at 7-Month Follow-up. Nicotine Tob Res. 2022 10 17; 24(10):1684-1688.
    View in: PubMed
    Score: 0.008
  34. Differences between adults who smoke cigarettes daily and do and do not co-use cannabis: Findings from the 2020 ITC four country smoking and vaping survey. Addict Behav. 2022 Dec; 135:107434.
    View in: PubMed
    Score: 0.008
  35. Gender parity and homophily in the Drug and Alcohol Dependence editorial process. Drug Alcohol Depend. 2022 07 01; 236:109493.
    View in: PubMed
    Score: 0.008
  36. Comparison of Medical Cannabis Use Reported on a Confidential Survey vs Documented in the Electronic Health Record Among Primary Care Patients. JAMA Netw Open. 2022 05 02; 5(5):e2211677.
    View in: PubMed
    Score: 0.008
  37. Cessation classification likelihood increases with higher expired-air carbon monoxide cutoffs: a meta-analysis. Drug Alcohol Depend. 2021 04 01; 221:108570.
    View in: PubMed
    Score: 0.007
  38. Remote Methods for Conducting Tobacco-Focused Clinical Trials. Nicotine Tob Res. 2020 12 12; 22(12):2134-2140.
    View in: PubMed
    Score: 0.007
  39. Increases in endogenous progesterone attenuate smoking in a cohort of nontreatment seeking women: An exploratory prospective study. Addict Biol. 2021 03; 26(2):e12918.
    View in: PubMed
    Score: 0.007
  40. Association of Cannabis Use With Intimate Partner Violence Among Couples With Substance Misuse. Am J Addict. 2020 07; 29(4):323-330.
    View in: PubMed
    Score: 0.007
  41. Sex Differences in Subjective and Behavioral Responses to Stressful and Smoking Cues Presented in the Natural Environment of Smokers. Nicotine Tob Res. 2020 01 27; 22(1):81-88.
    View in: PubMed
    Score: 0.007
  42. Efficacy and Safety of Varenicline for Adolescent Smoking Cessation: A Randomized Clinical Trial. JAMA Pediatr. 2019 12 01; 173(12):1146-1153.
    View in: PubMed
    Score: 0.007
  43. Depressive symptoms and cannabis use in a placebo-controlled trial of N-Acetylcysteine for adult cannabis use disorder. Psychopharmacology (Berl). 2020 Feb; 237(2):479-490.
    View in: PubMed
    Score: 0.007
  44. An electronic, smart lighter to measure cigarette smoking: A pilot study to assess feasibility and initial validity. Addict Behav. 2019 11; 98:106052.
    View in: PubMed
    Score: 0.006
  45. Pharmacological Treatment of Youth Substance Use Disorders. J Child Adolesc Psychopharmacol. 2019 08; 29(7):559-572.
    View in: PubMed
    Score: 0.006
  46. Blunts versus joints: Cannabis use characteristics and consequences among treatment-seeking adults. Drug Alcohol Depend. 2019 05 01; 198:105-111.
    View in: PubMed
    Score: 0.006
  47. Methods to reduce the incidence of false negative trial results in substance use treatment research. Curr Opin Psychol. 2019 12; 30:35-41.
    View in: PubMed
    Score: 0.006
  48. A Focused Career Development Program for Women Faculty at an Academic Medical Center. J Womens Health (Larchmt). 2018 12; 27(12):1474-1481.
    View in: PubMed
    Score: 0.006
  49. The effect of N-acetylcysteine on alcohol use during a cannabis cessation trial. Drug Alcohol Depend. 2018 04 01; 185:17-22.
    View in: PubMed
    Score: 0.006
  50. Incremental validity of estimated cannabis grams as a predictor of problems and cannabinoid biomarkers: Evidence from a clinical trial. Drug Alcohol Depend. 2018 01 01; 182:1-7.
    View in: PubMed
    Score: 0.006
  51. Reductions in cannabis use are associated with improvements in anxiety, depression, and sleep quality, but not quality of life. J Subst Abuse Treat. 2017 10; 81:53-58.
    View in: PubMed
    Score: 0.006
  52. A randomized placebo-controlled trial of N-acetylcysteine for cannabis use disorder in adults. Drug Alcohol Depend. 2017 08 01; 177:249-257.
    View in: PubMed
    Score: 0.006
  53. Alcohol consumption as a predictor of reactivity to smoking and stress cues presented in the natural environment of smokers. Psychopharmacology (Berl). 2017 Feb; 234(3):427-435.
    View in: PubMed
    Score: 0.005
  54. Mobile devices for the remote acquisition of physiological and behavioral biomarkers in psychiatric clinical research. J Psychiatr Res. 2017 02; 85:1-14.
    View in: PubMed
    Score: 0.005
  55. Coping strategies as a mediator of internet-delivered psychosocial treatment: Secondary analysis from a NIDA CTN multisite effectiveness trial. Addict Behav. 2017 02; 65:74-80.
    View in: PubMed
    Score: 0.005
  56. Alcohol use during a trial of N-acetylcysteine for adolescent marijuana cessation. Addict Behav. 2016 12; 63:172-7.
    View in: PubMed
    Score: 0.005
  57. Effects of intimate partner violence, PTSD, and alcohol use on cigarette smoking in a nationally representative sample. Am J Addict. 2016 06; 25(4):283-90.
    View in: PubMed
    Score: 0.005
  58. Gender Differences in Internalizing Symptoms and Suicide Risk Among Men and Women Seeking Treatment for Cannabis Use Disorder from Late Adolescence to Middle Adulthood. J Subst Abuse Treat. 2016 07; 66:16-22.
    View in: PubMed
    Score: 0.005
  59. The effects of N-Acetylcysteine on frontostriatal resting-state functional connectivity, withdrawal symptoms and smoking abstinence: A double-blind, placebo-controlled fMRI pilot study. Drug Alcohol Depend. 2015 Nov 01; 156:234-242.
    View in: PubMed
    Score: 0.005
  60. Increasing progesterone levels are associated with smoking abstinence among free-cycling women smokers who receive brief pharmacotherapy. Nicotine Tob Res. 2015 Apr; 17(4):398-406.
    View in: PubMed
    Score: 0.005
  61. Gender differences in responses to cues presented in the natural environment of cigarette smokers. Nicotine Tob Res. 2015 Apr; 17(4):438-42.
    View in: PubMed
    Score: 0.005
  62. An exploratory short-term double-blind randomized trial of varenicline versus nicotine patch for smoking cessation in women. Addiction. 2015 Jun; 110(6):1027-34.
    View in: PubMed
    Score: 0.005
  63. The Use of Technology in Participant Tracking and Study Retention: Lessons Learned From a Clinical Trials Network Study. Subst Abus. 2015; 36(4):420-6.
    View in: PubMed
    Score: 0.005
  64. Menstrual cycle phase effects in the gender dimorphic stress cue reactivity of smokers. Nicotine Tob Res. 2015 May; 17(5):607-11.
    View in: PubMed
    Score: 0.005
  65. Environmental tobacco smoke exposure among smokers and non-smokers receiving outpatient substance abuse treatment. Addict Behav. 2014 Dec; 39(12):1718-22.
    View in: PubMed
    Score: 0.005
  66. Internet-delivered treatment for substance abuse: a multisite randomized controlled trial. Am J Psychiatry. 2014 Jun; 171(6):683-90.
    View in: PubMed
    Score: 0.005
  67. Craving, cue reactivity, and stimulus control among early-stage young smokers: effects of smoking intensity and gender. Nicotine Tob Res. 2014 Feb; 16(2):208-15.
    View in: PubMed
    Score: 0.004
  68. Characteristics of an outpatient treatment sample by primary substance of abuse. J Addict Med. 2013 Sep-Oct; 7(5):363-71.
    View in: PubMed
    Score: 0.004
  69. Design and methodological considerations of an effectiveness trial of a computer-assisted intervention: an example from the NIDA Clinical Trials Network. Contemp Clin Trials. 2012 Mar; 33(2):386-95.
    View in: PubMed
    Score: 0.004
  70. Characterizing smoking topography of cannabis in heavy users. Psychopharmacology (Berl). 2012 Mar; 220(2):309-18.
    View in: PubMed
    Score: 0.004
  71. Age-related influence of contingencies on a saccade task. Exp Brain Res. 2006 Oct; 174(4):754-62.
    View in: PubMed
    Score: 0.003
  72. Cognitive control under contingencies in anxious and depressed adolescents: an antisaccade task. Biol Psychiatry. 2005 Oct 15; 58(8):632-9.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.